Bertagnolli: NIH funding cuts are “unprecedented and harmful” AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

Letai announces: NCI met FY26 goal of full funding payout

In a post on NCI’s LinkedIn, NCI Director Anthony Letai confirmed that the institute has fully awarded and paid out all of its grant funding for the Fiscal Year 2026.

October 16, 2026

Vol.52 No.38

By Claire Marie Porter

Podcast

As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”

As the oncology community waits with bated breath for a possible FDA approval of GRAIL’s Galleri test, NCI Director Anthony Letai has a lot to say about multi-cancer detection tests—particularly Galleri.

October 14, 2026

Cancer Policy

NIH awards $237.5M to advance biomedical and behavioral research

NIH has awarded 58 new research grants through its High-Risk, High-Reward Research program to support exceptionally innovative research with the potential for broad impact on biomedical and behavioral science.

October 09, 2026

Vol.52 No.37

Podcast

Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”

“I don’t know of a single grant that left my desk that was not approved and funded,” NCI Director Anthony G. Letai said on this episode of The Cancer Letter Podcast. https://open.spotify.com/episode/2PFYGwliBDYEbxBXFd9MtB?si=95DNBAy0QGSKBX31_uETEA This episode is available on Spotify, Apple Podcasts, and Youtube. Letai recapped his first year as NCI director in conversation with Paul Goldberg,...

October 07, 2026

Conversation with The Cancer Letter

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two
“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.

NIH introduces “Linked Discoveries,” a PubMed tool aimed at strengthening research replication, reproducibility

NIH has introduced Linked Discoveries, an experimental tool designed to help scientists more easily see how an individual research finding relates to the larger body of biomedical evidence.

October 02, 2026

Vol.52 No.36

Bertagnolli: NIH funding cuts are “unprecedented and harmful”

AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

YOU MAY BE INTERESTED IN

Letai announces: NCI met FY26 goal of full funding payout

As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”

NIH awards $237.5M to advance biomedical and behavioral research

Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two
“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”

NIH introduces “Linked Discoveries,” a PubMed tool aimed at strengthening research replication, reproducibility

Renew today!

Subscriber content

Never miss an issue!

Login

Bertagnolli: NIH funding cuts are “unprecedented and harmful”

AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

YOU MAY BE INTERESTED IN

Letai announces: NCI met FY26 goal of full funding payout

As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”

NIH awards $237.5M to advance biomedical and behavioral research

Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”

NIH introduces “Linked Discoveries,” a PubMed tool aimed at strengthening research replication, reproducibility

Never miss an issue!

Login

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two
“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”